Skip to main content

Psoriatic Arthritis News (Page 3)

Novartis Receives FDA Approval for Cosentyx (secukinumab) to Treat Patients with Ankylosing Spondylitis and Psoriatic Arthritis

EAST HANOVER, N.J., Jan. 15, 2016 Novartis announced today that the US Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) for two new indications - the treatment of adult...

FDA Approves Otezla (apremilast) to Treat Psoriatic Arthritis

March 21, 2014 – The U.S. Food and Drug Administration today approved Otezla (apremilast) to treat adults with active psoriatic arthritis (PsA). PsA is a form of arthritis that affects some people...

FDA Approves Cimzia for Treatment of Adult Patients with Active Psoriatic Arthritis

BRUSSELS, Sept. 30, 2013 /PRNewswire/ - UCB announced today that the U.S. Food and Drug Administration (FDA) has approved Cimzia (certolizumab pegol) for the treatment of adult patients with active...

Stelara (ustekinumab) Receives FDA Approval to Treat Active Psoriatic Arthritis

HORSHAM, Pa., Sept. 23, 2013 /PRNewswire/ – Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved Stelara (ustekinumab) alone or in combination with...

Horizon Pharma Announces FDA Approval of Rayos (prednisone) Delayed-Release Tablets for Rheumatoid Arthritis and Multiple Additional Indications

DEERFIELD, Ill., July 26, 2012 /PRNewswire/ – Horizon Pharma, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Rayos (prednisone) delayed-release tablets (1 mg, 2...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Spondyloarthritis

Related drug support groups

prednisone, methotrexate, Humira, triamcinolone, cortisone, Enbrel, Remicade, Otezla, Xeljanz, view more... Stelara, Cosentyx, Skyrizi, adalimumab, dexamethasone, etanercept, Taltz